Products

Exactech, Inc. announced today that the company has partnered with professional golfer Peter Jacobsen to tell the story of his successful knee replacement with Exactech’s Optetrak® total knee system in 2008.

LUMEDX Corporation & Mennen Medical® announced today the signing of a strategic partnership agreement to provide a total, integrated cath lab data solution and seamless stream of hemodynamic cardiovascular patient data to their customers.

Cordis Corporation, a worldwide leader in the field of interventional cardiology, announced plans today to launch a global, head-to-head, randomized clinical trial called NEVO II which will compare the NEVO™ Sirolimus-eluting Coronary Stent to the XIENCE V™ Everolimus-eluting Coronary Stent.

OrbusNeich Medical, Inc., a designer, developer, manufacturer and marketer of innovative medical devices for the treatment of vascular diseases, today announced that it has filed a lawsuit against Boston Scientific Corporation.

Susan D. DeVore has been named president and chief executive officer (CEO) of the Premier healthcare alliance. She and current CEO Rick Norling are starting now to coordinate the transition process.

Medtronic said Friday that at least 13 people might have died in connection with a heart device that it recalled in 2007 but was still in widespread use.

Medical device pioneer Stentys announced today that it has extended its ‘self-expanding’ and ‘disconnectable’ technology platform to include a second major indication—acute myocardial infarction.

Cardiac Science, a global leader in advanced cardiac diagnosis, resuscitation, rehabilitation, and informatics products, today announced the appointment of Dave Marver as the Company’s new President and Chief Executive Officer.

A comprehensive analysis published today in The Lancet from the ABSORB clinical trial demonstrated that Abbott’s bioabsorbable drug eluting stent successfully treated coronary artery disease and was absorbed into the walls of treated arteries within two years.

BioSyntech, Inc. today announced that it will conduct an interim analysis of the available clinical data from 40 subjects who have completed their 12 month follow-up in the 80 subject trial for its cartilage repair device, BST-CarGel®.

Educational Live Webcast Will Feature Hip Replacement Procedure Using Device Designed to Match Individual Patient Anatomy and Restore Hip Joint Kinematics – March 12, 2009 at 7:00 PM EDT

Injections of bone cement to support weakened bones in patients with metastatic bone disease provide immediate and substantial pain relief for patients, a researcher reported here at the Society of Interventional Radiology (SIR) 34th Annual Scientific Meeting.

Baxter International Inc. announced today that the U.S. Food and Drug Administration has classified Baxter’s January 23, 2009 Urgent Device Correction letter to customers regarding U.S. COLLEAGUE® Volumetric Infusion Pumps as a Class I recall.

St. Jude Medical, Inc. today announced European CE Mark approval of its Genesis® neurostimulation system for managing a form of chest pain known as chronic angina pectoris, or chronic angina.

K2M, Inc., a spinal device company developing innovative solutions for the treatment of complex spinal pathologies, announced the introduction of an all-inclusive solution for rigid posterior fixation of the cervico-thoracic regions of the spine, the CASPIAN™ Spinal System.

Doctors discharged 99-year-old Robert Manning from Fortis Malar Hospitals on Tuesday after a “challenging” hip replacement surgery in which the patient was not administered general anaesthesia.